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Although persistent viral diseases are a global health concern, the mechanisms of differential susceptibility to such
infections among individuals are unknown. Here, we report that differential interactions between dendritic cells (DCs)
and virus are critical in determining resistance versus susceptibility in the Theiler murine encephalomyelitis virus–
induced demyelinating disease model of multiple sclerosis. This virus induces a chronic demyelinating disease in
susceptible mice, whereas the virus is completely cleared in resistant strains of mice. DCs from susceptible mice are
more permissive to viral infection, resulting in severe deficiencies in development, expansion, and function, in contrast
to DCs from resistant mice. Although protective prior to viral infection, higher levels of type I interferons (IFNs) and
IFN-c produced by virus-infected DCs from susceptible mice further contribute to the differential inhibition of DC
development and function. An increased DC number and/or acquired resistance of DCs to viral infection render
susceptible mice resistant to viral persistence and disease progression. Thus, the differential permissiveness of DCs to
infectious agents and its subsequent functional and developmental deficiencies determine the outcome of infection-
associated diseases. Therefore, arming DCs against viral infection–induced functional decline may provide a useful
intervention for chronic infection-associated diseases.
Citation: Hou W, So EY, Kim BS (2007) Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog 3(8): e124. doi:10.1371/journal.ppat.
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Introduction
Susceptibility to immune-mediated diseases induced by
microbial infections varies between individuals. Several genes
involved in innate and adaptive immune responses are known
to be associated with such differential susceptibility [1,2].
Consequently, different levels and types of immune responses
to causative antigens are often correlated with susceptibility/
resistance to diseases. However, the underlying immune
mechanisms are largely unknown. Therefore, understanding
the mechanisms involved in the determination of resistance
versus susceptibility is a crucial step towards better disease
control. Recent studies have indicated that dendritic cells
(DCs) play a critical role in the induction and maintenance of
strong immunity to infectious agents [3]. Thus, it is
conceivable that the differential responsiveness of DCs to
an identical pathogen in resistant and susceptible individuals
may lead to disparate levels of protective and/or pathogenic
immunity, resulting in differential susceptibility to virus-
associated diseases. In this study, we examine this possibility
using the Theiler murine encephalomyelitis virus (TMEV)–
induced demyelinating disease model for multiple sclerosis
(MS).
TMEV is a picornavirus that causes chronic demyelination
in the white matter of the central nervous system (CNS) of
susceptible mice, such as SJL/J (SJL), following the establish-
ment of persistent infection [4]. This demyelinating disease
has immune parameters and histopathology similar to those
of chronic progressive MS and thus is extensively studied as
an infectious model for MS [4]. However, susceptibility to
persistent infection and demyelination varies among inbred
strains of mice. For example, in contrast to susceptible SJL
mice, resistant strains of mice such as C57BL/6 (B6) are able
to completely clear the virus and do not develop late chronic
demyelinating disease [5,6]. Many previous studies have
indicated that TMEV clearance from the CNS is mainly
mediated by CD8
þ cytotoxic T lymphocytes (CTLs) [7–9],
although such T cells may also be pathogenic, particularly
during chronic demyelinating disease. The anti-viral CTL
response in resistant mice is signiﬁcantly more rapid and
intense compared to that of susceptible mice [10,11],
suggesting that this response is critical in preventing the
establishment of viral persistence. Similarly, the level of virus
capsid–speciﬁc CD4
þ T cell response following viral infection
in resistant mice is signiﬁcantly higher than that in
susceptible mice, despite the higher level of overall CD4
þ T
cell inﬁltration in the CNS of susceptible mice [12]. These
results demonstrate that lower levels of initial anti-viral T cell
response in susceptible mice may consequently allow the
virus to establish chronic persistence. However, the under-
lying cellular mechanisms involved in such differential levels
of anti-viral immune responses between susceptible and
resistant mice are not fully understood.
DCs play a central role in the initiation of both innate and
adaptive immune responses to infectious agents, including
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mucosa, and in lymphoid organs, where they efﬁciently take
up diverse microbial antigens, then process and present them
as major histocompatibility complex (MHC)–peptide com-
plexes to T cells. Following the recognition of pathogens, DCs
undergo a series of activation processes. Once activated, DCs
migrate into the T cell zone of lymphoid organs, where
antigen-speciﬁc immune cells can be primed. Migration
coincides with a maturation process that results in morpho-
logical, phenotypic, and functional changes. Moreover,
activated DCs have the capacity to recruit and/or activate
cells of the innate and adaptive immune systems [3]. However,
DC function and its consequent adaptive immune response
depend largely upon the interaction between DCs and
microbial signals, which can enhance or impair DC function
via Toll-like receptors, c-type lectins, CD40, cytokine recep-
tors, or other pathways [3].
Interestingly, several research groups have recently shown
the presence of DCs in the meninges and choroid plexus of
healthy rodents [13–16]. Moreover, recent studies have
demonstrated that local antigen-presenting cells (APCs),
possibly DCs, can activate naı ¨ve T cells that enter the
inﬂamed CNS [17]. It has also been noted that the DCs
associated with CNS vessels are sufﬁcient to prime myelin-
reactive T cells in vivo, resulting in CNS inﬂammation and
clinical disease [18]. Thus, it is possible that neurotropic
TMEV evades immune recognition and establishes latency by
subverting DC function in susceptible strains of mice, but not
in resistant mice. In this study, we address the role of DC
responses in viral persistence and its consequent demyelinat-
ing disease in prototypically susceptible SJL and resistant B6
mice. We sought to answer the following questions: First, is
the level of viral infection/replication in DCs from susceptible
mice greater than that of resistant mice? Second, are DC
differentiation and activation/maturation preferentially im-
paired in susceptible mice? If this is the case, what are the
major mechanisms involved in these differential DC re-
sponses following viral infection? Finally, can an increased
DC number and/or acquired resistance to viral infection
rescue susceptible mice from chronic viral persistence and
from developing demyelinating disease?
Results
Enhanced TMEV Replication in DCs from Susceptible Mice
Blocks DC Maturation
There are signiﬁcant differences in persistent viral in-
fection and its consequent demyelinating disease between SJL
and B6 mice. To examine whether these differences may be
associated with differential susceptibility of DCs to TMEV
infection, bone marrow (BM) DCs were studied for expression
of TMEV antigens and virus production. TMEV was able to
bind equally well to DCs from either susceptible SJL or
resistant B6 mice (Figure 1A). However, ultraviolet (UV)-
inactivated TMEV failed to bind DCs from SJL and B6 mice,
which is consistent with the abrogation of receptor-mediated
binding of other picornaviruses by UV inactivation [19].
These ﬁndings suggest that the binding of TMEV to DCs is
not due to non-speciﬁc stickiness. In addition, TMEV
þ cells
were detected by 6 h post-infection in the SJL DCs, but not at
1 h post-infection, suggesting that new protein synthesis was
required for the detection (Figure 1B). In contrast to SJL DC
cells, DC cells from B6 mice were far less susceptible to
infection, and the virus yield in single-step growth curves
from B6 cultures was approximately one log lower than that
from SJL cultures (Figure 1B, right panel). Differences in DC
viral infection between SJL and B6 mice were evident
throughout several days of culturing BM cells (BMCs) (Figure
1C), despite comparable levels of CD11c in both SJL and B6
DCs (unpublished data). Even on the peak day, day 6, the level
of viral infection in SJL DCs was signiﬁcantly greater (.3-
fold) than that of B6 DCs (Figure 1C). It was clear in these
experiments that the cells producing viral proteins were
CD11c
þ(Figure 1B), suggesting that DCs produce the majority
of infectious virus. In fact, assessment of viral production
from isolated CD11c
þ and CD11c
  cells following viral
infection conﬁrmed that the great majority of BMCs
producing virus proteins (.95%) are CD11c
þ and the rest
(,5%) are CD11c
  cells (Figure S1A and S1B). Furthermore,
the level of infectious virus produced by CD11c
þ cells is over
40-fold higher than that produced by CD11c
  cells (Figure
S1A and S1C). A similar differential virus replication in
splenic DCs between these mouse strains was also observed
(Figure S1D).
Phenotypic analysis of the infected DC cells suggested that
virus preferentially infects immature DCs and prevents their
maturation. As shown in Figure 1D, the TMEV
þ cells in either
SJL or B6 cultures were MHC class II
low, CD86
low, and
CCR7
low, molecules whose expression is enhanced only
during DC maturation. Interestingly, when compared to
mock-infected cells, lower levels of expression of MHC class
II, CD86, or CCR7 were also observed in infected SJL cultures,
even in cells that were not TMEV
þ. For example, 64% of
mock-infected cells expressed MHC class II while only 22% of
the TMEV
  cells in the SJL cultures expressed the molecule.
This suggests that the maturation of uninfected DCs is altered
in the SJL cultures, possibly indirectly via soluble factors
produced by virus-infected cells. This potential bystander
effect will be discussed further in the next section. In
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Author Summary
Many chronic viral diseases are associated with prolonged viral
persistence levels, which vary from one individual to another.
However, the mechanisms of differential susceptibility to persistent
viral infections are unknown. Theiler murine encephalomyelitis virus
(TMEV) induces a chronic demyelinating disease similar to multiple
sclerosis. In this study, we investigated the potential mechanisms of
differential susceptibility to chronic viral persistence in the central
nervous system following infection with TMEV. Our results indicate
that differential interactions between virus and dendritic cells (DCs),
leading to the induction of anti-viral immunity, are critical in
determining resistance or susceptibility to virus-induced chronic
demyelinating disease. DCs from susceptible mice are much more
permissive to viral infection, resulting in severe deficiencies in their
development, expansion, and function, whereas DCs from resistant
mice are not permissive. Consequently, the DCs in susceptible mice
are responsible for poor anti-viral T cell activation, permitting viral
persistence and disease development in the host. Interestingly, the
administration of additional DCs or pre-activated virus-resistant DCs
enables susceptible mice to resist persistent viral infection and
disease development. This knowledge may be useful in devising
effective means to induce strong anti-viral immune responses,
thereby protecting the host from virus-associated chronic diseases
caused by persistent viral infection.contrast, infected B6 DC cultures did not show dramatic
reductions in their maturation-associated markers. These
data strongly suggest that TMEV preferentially replicates in
immature DCs and that, in the case of SJL DCs, arrests their
maturation.
To exclude the possibility that resistance to persistent
TMEV infection in the B6 strain is attributed to the
expression of the H-2D
b gene [20], DCs from B10 (H-2
b)
and B10.S (H-2
s) mice, which are relatively resistant to TMEV-
induced demyelinating disease compared to susceptible SJL
(H-2
s) mice [21], were also examined. Interestingly, our results
show that BM DCs from resistant B10 (H-2
b) and B10.S (H-2
s)
are similarly resistant to viral infection compared to
susceptible SJL (H-2
s) mice (Figure S2). Thus, these results
strongly suggest that differences in viral infection/replication
levels in DCs do not reﬂect the H-2 differences, and that
differential susceptibility of DCs correlates closely with
susceptibility to TMEV-induced demyelinating disease.
Cytokines Produced by TMEV-Infected DCs Affect DC
Activation
To investigate the potential mechanisms for bystander
inhibition of DC maturation, cytokines produced in infected
DC cultures were examined after 5 d of culture. As shown in
Figure 2A, infected cultures produced higher levels of IL-
12p40, IL-6, and interferon (IFN)-a than mock-infected
controls. Differences in TNF-a and IL-10 were not observed.
Interestingly, infected SJL DCs produced signiﬁcantly more
IL-6 and IFN-a than the B6 counterparts. Infection of SJL
DCs induced the expression of mRNAs of several IFNs (Figure
2B) with fairly rapid kinetics (8 h post-infection), suggesting
that these are direct consequences of the infection. These
included type I IFNs (IFN-a1, IFN-a2, IFN-a4, IFN-a5, IFN-a6,
IFN-a7, IFN-a9, IFN-a11, IFN-ab, and IFN-b), and a type II
IFN (IFN-c). Figure 2B shows representative examples. In
contrast, the levels of other IFNs, such as epsilon, kappa, and
lambda, were not signiﬁcantly different (unpublished data).
The ﬁnding that high levels of IFNs are produced by SJL-
infected DCs is of importance because these cytokines were
found to block the activation of DCs (Figure 2C). When SJL
DCs were pretreated with IFN-a , IFN-b, or IFN-c for 18 h,
then stimulated with lipopolysaccharide (LPS) for the ﬁnal 6
h of culture, DCs produced dramatically less IL-12p40, IL-6,
and TNF-a. Interestingly, pretreatment with IFN-c, but not
IFN-a or IFN-b, enhanced IL-10 production, suggesting
potential differences among these IFNs in inhibiting DC
function (Figure 2C). IL-6, the major cytokine produced by
TMEV-infected DCs, had only marginal effects on DC
function, which suggests that type I and II IFNs are primarily
responsible for the virus-induced inhibitory effects on DC
activation.
IFNs Produced by DCs upon LPS Treatment or TMEV
Infection Transiently Limit Viral Infection
TMEV was shown to infect immature DCs in Figure 1B,
blocking their maturation. In contrast, TMEV does not
Figure 1. Elevated Viral Replication and Reduced Maturation of SJL DCs following TMEV Infection
(A) For the virus binding assay, DCs obtained from a 5-d culture of primary BM cells were incubated with UV-inactivated TMEV or TMEV (MOI 10) for 1 h
at 4 8C, fixed with 1% PFA, and stained with anti-TMEV monoclonal antibody (open histogram) or isotype antibody (filled histogram) followed by FITC-
conjugated secondary antibody.
(B) To determine viral infection and replication levels, DCs were infected at MOI 10 for 1, 6, 12, 24, and 48 h. Expression of TMEV proteins in DCs was
detected using anti-TMEV mAb and anti-CD11c antibody. Virus production was assessed by plaque assay.
(C) The fraction of virus protein-positive cells was determined at different stages of culture of BMCs.
(D) DCs were infected for 24 h and then analyzed for levels of maturation-associated markers (MHC-II, CD86, and CCR7, y-axis) and TMEV protein (x-axis)
by intracellular staining with gated CD11c
þ cells.
doi:10.1371/journal.ppat.0030124.g001
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ligand (Figure 3A). A variety of TLR ligands, including viral
components, are known to induce activation, maturation,
and/or cytokine production in DCs [3]. Pretreatment of DCs
with LPS greatly reduces the numbers of TMEV
þ cells in the
culture, but treatment of DCs with LPS after infection has no
effect. The addition of LPS at the time of infection had only a
partial effect. The reduced infection in cells pretreated with
LPS was correlated with restored DC cytokine production
(Figure 3B). DCs induced by LPS produce the cytokines IL-
12p40, IL-6, TNF-a, and IL-10. TMEV preinfection signiﬁ-
cantly blocked the ability of these cells to produce IL-12p40,
IL-6, and TNF-a in response to LPS. In contrast, when DCs
were treated ﬁrst with LPS, cytokine production was not
inhibited by the TMEV infection. These results suggest that
LPS pretreatment results in inhibition of viral replication
and restoration of cytokine production. These patterns were
similar in DCs of both SJL and B6 mice, although the levels of
viral infection remain higher in SJL DCs compared to B6 DCs.
Interestingly, a different pattern was found again with IL-10,
and infected SJL DCs produced signiﬁcantly higher levels of
this cytokine in response to LPS.
The ﬁndings that virus-infected cells produce IFNs (Figure
2A) and that IFNs reduce the ability of DCs to respond to
LPS (Figure 2C) suggest an IFN-mediated inhibition of DC
maturation by viral infection. The IFNs produced by infected
cells can reduce DC maturation, even in the uninfected cells
in the culture, which explains the apparent bystander effect
seen in Figure 1D. In addition, the IFNs not only blocked DC
maturation, but they also prevented viral infection in
Figure 2. Cytokines Produced by Infected DCs and Their Effects on DC Activation
(A) SJL and B6 DCs of a 5-d culture of BMCs were infected with TMEV for 24 h and concentrations of cytokines secreted were determined by ELISA.
Statistically significant differences from the values in mock-infected DCs are indicated with asterisks (*, p , 0.05; **, p , 0.01; ***, p , 0.001).
(B) SJL and B6 DCs were infected with TMEV for 8 h. Total RNAs from DCs were prepared for quantitative real-time PCR analysis. Data are expressed by
fold increases as compared to mock-infected cells. Results are shown as mean plus SD.
(C) SJL DCs were treated with IFN-a (1,000 U/ml), IFN-b (1,000 U/ml), IFN-c (10 ng/ml), IL-6 (100 ng/ml), or left untreated for 24 h. LPS was added for the
final 6 h of culture. Cytokine levels in supernatants were determined with ELISA. Statistical differences between the values of untreated and treated DCs
are indicated with asterisks (*, p , 0.05; **, p , 0.01).
doi:10.1371/journal.ppat.0030124.g002
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were actually able to increase the numbers of TMEV
þ cells in
DC cultures (unpublished data). These results are consistent
with the possibility that the inhibitory effect of LPS on TMEV
infection is mediated by IFNs produced by LPS-treated DCs.
It is, therefore, important to note that TMEV-infected SJL
DCs produce higher levels of IFNs than infected B6 cells.
Even though more virus is produced in the initial infection of
SJL DCs, the increased levels of IFNs produced would limit
the spread of the infection to neighboring cells. This idea was
conﬁrmed by experiments in which supernatants from virus-
infected cultures were used to pretreat DC cells (Figure 3D).
Pretreatment of fresh DC cells with cell-free culture media
from SJL-infected cells dramatically reduced the numbers of
Figure 3. Inhibition of Viral Infection in DCs Pretreated with LPS or IFNs
(A) LPS was added 6 h before infection (pre-LPS), simultaneously (sim-LPS), or 18 h after infection (post-LPS). DCs were infected with virus for 24 h and
then scored by staining for intracellular viral proteins.
(B) DCs were cultured with or without LPS for 6 h, washed twice, and then infected by TMEV for 24 h. After 18 h infection, LPS was added for the final 6
h of culture. Cytokine production was determined with specific ELISA. The differences between the values of mock-infected and TMEV-infected DCs are
highly significant (***, p , 0.001).
(C) IFN-a (100 U/ml), IFN-b (100 U/ml), or IFN-c (1 ng/ml) was added to SJL DCs 6 h before infection (pre-6 h), simultaneously (sim) with infection, or 6 h
after infection (post-6 h). All groups of DCs were infected with TMEV for 24 h. Expression of TMEV proteins in DCs was detected using anti-TMEV mAb
and anti-CD11c antibody.
(D) Mock- or TMEV-infected SJL DC supernatants were collected after 24 h of infection, and live virus in the supernatants was inactivated with UV. Cell-
free supernatants (400 ll/ml) were added to freshly prepared IFN-a/bR-sufficient and -deficient DCs and incubated for 6 h, prior to infection with TMEV
for 24 h. Parallel DC cultures were pretreated with LPS or PBS for 6 h. The ability of the fresh DCs to produce viral antigens was detected using anti-
TMEV mAb and anti-CD11c antibody.
doi:10.1371/journal.ppat.0030124.g003
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þ cells in the new cultures. When DC cells from IFN-a/b
receptor knockout (IFN-a/bR) animals were infected with
TMEV, the culture supernatants did not effectively block a
subsequent infection (Figure 3D, right panel), suggesting that
the supernatants inhibit viral infection mainly in a type I
IFN–dependent manner. In addition, LPS pretreatment
failed to inhibit TMEV replication in IFN-a/bR-deﬁcient
DCs (Figure 3D), indicating the involvement of type I IFNs in
the resistance of normal DCs acquired by pretreatment with
LPS. However, IFN-a/bR-deﬁcient DCs remained partially
resistant to viral infection following pretreatment with
infected culture supernatants, strongly suggesting that there
is a cytokine(s) blocking in a type I IFN–independent
manner.
TMEV Infection Preferentially Inhibits SJL DC Expansion In
Vitro
Since an adequate number of DCs is necessary to elicit
strong innate and adaptive anti-viral immune responses, a
substantial reduction of DCs resulting from viral infection
may allow viruses to evade immune recognition [22]. To test
the possibility that TMEV infection inhibits DC expansion
from hematopoietic progenitors, BMCs that were cultured
for 3 d in the presence of granulocyte monocyte colony-
stimulating factor (GM-CSF) were infected with TMEV, and
the rate of DC expansion was subsequently assessed. Only a
few small clusters of proliferating cells were observed in
virus-infected SJL BMCs at 3 days post-infection (dpi),
compared to mock-infected cultures (Figure 4A). In sharp
contrast to SJL BMCs, many large aggregates of proliferating
cells were evident in virus-infected B6 BMC cultures, similar
to that of mock-infected BMCs (Figure 4A). The total number
of SJL BMCs infected with TMEV continuously declined
during the 4-d culture period, whereas the total number of
virus-infected B6 BMCs increased slightly, although the rate
of increase was signiﬁcantly lower than that of mock-infected
cultures (Figure 4B). Furthermore, BMCs infected with TMEV
failed to differentiate into plasmacytoid DCs or macrophages,
as the majority of cells showed CD11c
þ CD45RA
 CD11b
þF4/
80
  phenotype (unpublished data).
It is conceivable that the suppression of DC expansion is in
part due to the apoptosis of BMCs induced by TMEV
infection. To evaluate this possibility, we examined the levels
of BMC apoptosis at 24, 48, and 72 h post-infection. The
proportions of Annexin V–positive cells undergoing apopto-
sis were signiﬁcantly higher in TMEV-infected SJL BMCs
compared to those in B6 BMCs during the culture periods
(shown at 24 h post-infection in Figure 4C; unpublished data).
Thus, SJL DCs are substantially more susceptible not only to
viral infection but also to virus-induced apoptosis, and this
certainly contributes to the failure of DC expansion from
hematopoietic progenitors. The preferential apoptosis of SJL
DCs may also contribute to the drastic inhibition of SJL DC
expansion. However, not all infected DCs are undergoing
apoptosis. As shown in the bottom experiment of Figure 4C,
when cells infected for 24 h were isolated into apoptotic
(Annexin V–positive) and non-apoptotic fractions, a signiﬁ-
cant number of Annexin V–negative, TMEV
þcells were found
to be present (22% in SJL versus 5% in B6). It is conceivable
that these cells may also be deﬁcient in their expansion. This
possibility was conﬁrmed by measuring the loss of carboxy-
ﬂuorescein diacetate succinimidyl ester stain 3 d after
infection (Figure 4D). DCs from SJL mice showed poor
proliferation (30% in infected cultures versus 90% in control
cultures). In contrast, DCs from B6 mice (73%) showed
signiﬁcant loss of staining intensity, consistent with ongoing
cell divisions.
The arrest of DC precursors following infection in SJL
cultures is likely to reﬂect the increased production of IFNs,
which is known to block DC expansion [23]. Indeed, when
IFN-blocking antibody was included in CFSE experiments,
the proliferation of infected SJL DCs was enhanced (unpub-
lished data). It was shown in Figure 3D that culture super-
natants from TMEV-infected DCs produced cytokines that
blocked further infection, but only when cells from IFNa/bR-
sufﬁcient mice were used. Similarly, culture supernatants
were able to block the expansion of hematopoietic cell
precursors (Figure 4E). The inhibition was dose dependent
and the activity of supernatants from infected SJL cells was
signiﬁcantly higher than that of supernatants from infected
B6 cells. Type I and II IFNs also similarly reduced cellular
expansions. Experiments with IFN-a/bR-deﬁcient DCs indi-
cated that type I IFNs and other inhibitory cytokines, most
likely IFN-c, were responsible for the arresting activity of SJL
supernatants (unpublished data). Taken together, these
results indicate that BMCs from susceptible SJL mice, but
not from resistant B6 mice, are highly permissive to viral
infection, leading to virus-induced apoptosis and the pro-
duction of high levels of regulatory cytokines, including type I
IFNs, IFN-c, and perhaps IL-6, resulting in growth arrest of
BMCs.
Lower DC Numbers Are Present in TMEV-Infected
Susceptible SJL Mice
To examine the effects of TMEV infection on SJL and B6
DCs in vivo, phenotypic and functional alterations in DCs
from BM, spleen, and CNS of infected mice were analyzed.
Interestingly, levels of CD11c
þ DC populations in the BM and
spleen from uninfected naı ¨ve SJL mice were signiﬁcantly
lower than those in naı ¨ve B6 mice (p , 0.01) (Figure S3A).
After TMEV infection, the number of B6 DCs in BM rapidly
increased at 2 dpi (p , 0.05) and then decreased to a basal
level at 4 dpi, whereas the number of SJL DCs remained low
throughout. Similarly, the number of DCs in the spleens of B6
mice gradually increased (p , 0.05), whereas no signiﬁcant
increase was seen in SJL mice. In addition, the levels of DCs
undergoing apoptosis in the BM and spleens of virus-infected
SJL mice were greater than those of infected B6 mice (Figure
S3B). Therefore, lower DC numbers in virus-infected SJL
mice are consistent with their differential susceptibility to
apoptosis and growth arrest induced by TMEV infection in
vitro (Figure 4).
The accumulation of DCs in the CNS has been reported in
mice with local injections of heat-killed BCG [16] and EAE
[24]. Thus, we examined the properties of DCs in the CNS, the
virus target organ following TMEV infection. The number of
inﬁltrating CD45
hiCD11c
þ DCs in the CNS of infected B6
mice was signiﬁcantly higher (.2-fold) than that of SJL mice
(Figure 5A). In particular, B6 mice showed greater levels of
myeloid CD11b
þ DCs, but decreased levels of lymphoid
CD8a
þ DCs, compared to SJL mice (Figure S4A). In contrast,
splenic CD8a
þ DC levels were lower in SJL mice compared to
B6 mice, suggesting a differential distribution of this DC
population between resistant and susceptible mice, which
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S4B). Since TNF-a and/or IL-12 are important cytokines in
the migration, accumulation, and activation of DCs involved
in the elicitation of anti-viral immunity [3], these cytokines
were examined at 5 dpi (Figure 5B). Very low levels of these
cytokines were observed in unstimulated DCs from the CNS
of TMEV-infected mice. After stimulation with LPS, cytokine
production by DCs was enhanced in infected B6, but poorly
in SJL, mice. Similarly, DCs from the spleens of virus-infected
SJL mice, but not B6 mice, were refractory to cytokine
production in response to LPS stimulation (Figure 5C). This
result was conﬁrmed with supernatants from isolated splenic
DCs from mock- and TMEV-infected mice to exclude the
cytokines produced by non-DC population (Figure 5D).
Figure 4. Inhibition of DC Expansion following TMEV Infection via Apoptosis and Growth Arrest
(A) BMCs were cultured with GM-CSF for 3 d and then mock-infected or infected with TMEV. Phase contrast micrographs (3100) of BMCs were taken at 3
dpi.
(B) BMC cell numbers were determined at day 0 and 2, 3, and 4 dpi.
(C) Cells obtained from 3-d BM cultures were infected with TMEV (MOI 10) for 24 h and then labeled with Annexin V. The Annexin V–positive and
–negative cells were isolated using an Annexin V MicroBead kit. Cells were then fixed, permeabilized, and stained with anti-TMEV mAb and anti-CD11c
antibody.
(D) BMCs cultured with GM-CSF for 3 d were stained with CFSE and then infected with TMEV. The decrease of CFSE fluorescence in DCs was determined
using anti-CD11c antibody at 3 dpi as shown.
(E) BM cells from SJL mice were cultured with 4 ll/ml, 40 ll/ml, or 400 ll/ml of UV-inactivated supernatants from TMEV-infected SJL DCs (SJL-sup) or B6
DCs (B6-sup). BM cells were also cultured with rIFN-a, rIFN-b (10 U/ml, 100 U/ml, and 1,000 U/ml), rIFN-c (0.1 ng/ml, 1 ng/ml, and 10 ng/ml), or rIL-6 (1
ng/ml, 10 ng/ml, and 100 ng/ml). Increasing concentrations of supernatants or cytokines are denoted by the dotted bars, then striped bars, and,finally,
the solid bars. Mock-infected SJL DC and B6 DC supernatant (400 ll/ml) and PBS were included as controls (open bars, respectively). Cell numbers in the
cultures were analyzed after incubation in GM-CSF-supplemented medium for 6 d. Statistically significant differences between the numbers of DCs
treated with mock-infected supernatant or PBS and DCs treated with TMEV-infected supernatant or cytokines, respectively, are indicated with asterisks
(*, p , 0.05, **, p , 0.01, ***, p , 0.001).
doi:10.1371/journal.ppat.0030124.g004
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severely interferes with the survival, CNS accumulation, and
function of DCs in susceptible SJL mice, but not in resistant
B6 mice.
TMEV Infection Preferentially Impairs the T Cell
Stimulatory Function of SJL DCs
Mixed lymphocyte responses (MLRs) induced by infected
DCs were assessed as a measure of DC function. T cells from
naı ¨ve BALB/c mice were co-cultured with either SJL or B6 BM
DCs infected in vitro with virus for 1 d (unpublished data) or
3 d (Figure 6A). The allostimulatory function of virus-infected
SJL DCs was severely compromised compared to that of
either mock-infected or TMEV-infected B6 DCs. DCs isolated
from infected SJL mice were similarly impaired in their
ability to drive the MLR (Figure 6B). It is unlikely that this
differential reduction in the T cell stimulatory function of
SJL DCs is due to infectious virus released from DCs during T
cell stimulation, since paraformaldehyde (PFA)-ﬁxed virus-
infected SJL DCs similarly failed to stimulate allogeneic T
cells (Figure 6A).
Key cytokines produced during allogeneic T cell responses
were measured using either BM cells infected in vitro (Figure
6C) or splenic DCs from infected mice (Figure 6D). Interest-
ingly, T cells stimulated with either of these sources of
infected SJL DCs failed to produce IFN-c but gained the
ability to produce IL-4, as compared to mock-infected
counterparts. In contrast, there was no signiﬁcant difference
in cytokine production when T cells were stimulated with
virus-infected or mock-infected B6 DCs. These results
strongly suggest that TMEV infection converts SJL DCs from
Th1 stimulation to Th2 stimulation, while this infection has a
minimal effect on B6 DCs. Since virus-speciﬁc Th1 cells are
known to be more protective than Th2 cells [7,8], such a
switch in CD4
þT cell types may also facilitate the preferential
persistence of virus in the CNS of susceptible SJL mice.
Consistent with the above altered T cell differentiation, the
expression levels of CD69, an indicator of T cell activation,
and TIM-3, a Th1-associated marker, were reduced when
TMEV-infected SJL DCs, but not B6 DCs, were cultured with
naı ¨ve T cells (Figure 6E). Similar patterns of CD69 and TIM-3
expression on T cells were also observed with splenic DCs
from TMEV-infected mice (Figure 6F). These results are
consistent with the differential Th1/Th2 stimulation ex-
hibited by SJL and B6 DCs following TMEV infection in
vitro as well as in vivo. It is important to note that the
Figure 5. Reduced Number and Ability of DCs to Produce Cytokines in TMEV-Infected SJL Mice
(A) The percentage of CD45
hiCD11c
þ cells (relative to total CD45
hi cells) and the total number of DC cells in the CNS of virus-infected mice (three mice
per group) were determined at 3 and 5 dpi. Differences between virus-infected SJL and B6 mice are significant (**, p , 0.01).
(B) CNS-infiltrating cells from virus-infected mice (three mice per group) at 5 dpi were stimulated with PBS or LPS for 6 h and then stained for CD11c and
IL-12. Data are gated on CD11c
þ cells. The percentage of TNF-a- or IL-12-positive cells relative to total CD11c
þ cells is indicated.
(C) Splenocytes from mock-infected or TMEV-infected mice were prepared at 7 dpi, then stimulated with PBS or LPS for 6 h and stained for CD11c, CD8a
and IL-12. Data are shown with gated CD11c
þ cells.
(D) DCs purified from the spleens of mock-infected or TMEV-infected mice at 7 dpi were stimulated with GM-CSF overnight, followed by incubation with
PBS or LPS for the final 6 h. IL-12p40 was determined by ELISA. Statistically significant differences from the values of mock-infected mice are indicated
with asterisks (*, p , 0.05).
doi:10.1371/journal.ppat.0030124.g005
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þ T cells are similarly
reduced after stimulation with infected SJL DCs or DCs from
infected mice compared to those from B6 mice (Figure 6E
and 6F), suggesting that CD8
þ T cell stimulation is also
compromised.
DC Administration Confers Protection from Chronic
Demyelinating Disease in SJL Mice
The reduction in DC number and function in SJL mice may
contribute to their greater susceptibility to demyelinating
infections. Thus, interventions to enhance DC function might
reduce the occurrence of disease in these animals. To explore
this possibility, SJL mice were intracerebrally infected with
TMEV alone or along with syngeneic DCs, LPS-pretreated
DCs (LPS-DCs), or non-DC splenocytes (Figure 7). The LPS-
DC group was included because LPS-DCs are resistant to
TMEV infection and maintain their function (Figure 3A and
3B). At 7 dpi, macrophage levels (CD45
hiCD11b
þ) and virus-
speciﬁc IFN-c-producing CD8
þ T cells in the CNS were
signiﬁcantly higher in mice infected with virus plus either
untreated DCs or LPS-DCs, compared to those in mice
infected with virus alone or virus plus non-DC splenocytes
(Figure 7A). Control mice receiving LPS-DCs alone failed to
accumulate a signiﬁcant level of leukocytes in the CNS
(Figure 7A). The percentage of virus-speciﬁc CD8
þ T cells in
the spleens of these mice was low but correlated with the
number of CNS-inﬁltrating T cells. The group that received
virus plus LPS-DCs displayed the highest (5.4%) level among
all experimental groups (unpublished data). These data
indicate that supplying additional DCs, particularly virus-
resistant LPS-DCs, facilitates cellular inﬁltration to the CNS
and elicitation of a strong CTL response against the virus.
To relate levels of virus-speciﬁc CD8
þ T cells to viral
persistence, the viral load in brains and spinal cords was
analyzed by plaque assay (Figure 7B). Levels of virus in the
CNS were inversely correlated to the number of virus-speciﬁc
CD8
þ T cell levels; viral persistence was signiﬁcantly lower in
mice that received either LPS-DCs or untreated DCs, which
resulted in higher CD8
þ T cell responses. The same patterns
of viral persistence were maintained at 21 dpi, although the
Figure 6. Inhibition of Allogenic T Cell Stimulation by TMEV-Infected DCs
BM DCs were infected with TMEV in vitro for 3 d, and then varying numbers of unfixed or fixed BM DCs were cultured with 1310
5 of naı ¨ve T cells from
BALB/c mice. To study in vivo infected cells, DCs were isolated from the spleens of mock- or TMEV-infected mice at 7 dpi, then co-cultured with naı ¨ve T
cells. Cells and culture supernatants were collected after 96 h of co-culture.
(A, B) T cell proliferation was measured as the mean 6 SD of (
3H)-thymidine uptake from triplicate cultures.
(C, D) IFN-c and IL-4 produced in culture supernatants (DC:T¼1:10) were determined by ELISA. UD, undetectable. **, significant differences between the
values in TMEV- and mock-infected cultures (p , 0.01). Data from BM DCs infected in vitro are shown in (C), and those from infected mice in (D).
(E, F) The effect of co-culture with infected DCs on the expression of CD69 or TIM-3 on T cells (DC:T ¼ 1:10) was determined by FACS. The numbers
represent the percentage of CD69- or TIM-3-positive cells relative to total CD4
þ or CD8
þ T cells.
doi:10.1371/journal.ppat.0030124.g006
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Dendritic Cells in Chronic Viral InfectionFigure 7. Enhanced CTL Responses, Viral Clearance, and Protection from Demyelinating Disease following DC Transfer into Susceptible Mice
BM DCs pretreated with LPS for 6 h (LPS-DCs), untreated DCs, and non-DC splenocytes (1 3 10
5 cells/per mouse) together with TMEV (1 3 10
6 pfu/
mouse) or virus alone (no DC) were intracerebrally injected into SJL mice.
(A) Assessment of levels of CD45
hi cells, CD45
hiCD11b
þcells, and virus-reactive CD8
þT cells in the CNS of virus-infected mice (three mice per group) at 7
dpi. *, p , 0.05 and **, p , 0.01 compared to values in mice infected with virus alone. n.d., not done.
(B) Level of viral persistence in brains or spinal cords (three mice per group) was assessed by plaque assay at 7 and 21 dpi. UD (undetectable) represents
virus levels lower than 24 pfu/per tissue. *, p , 0.05 and **, p , 0.01 between the experimental groups and the control group infected with virus alone.
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the incidence and severity of demyelinating disease (Figure
7C and 7D) were reduced in animals with high levels of the
anti-viral CD8
þ T cell response and viral clearance. Mice
receiving LPS-DCs, and to a lesser extent, mice receiving
untreated DCs, were more resistant (p , 0.001 and p , 0.01,
respectively) to virally induced demyelinating disease than
control mice receiving non-DC splenocytes. Abundant
inﬂammatory foci and areas of myelin stripping were
prominent within the white matter of spinal cords from
mice receiving non-DC splenocytes (Figure 7D). However,
only limited levels of inﬂammatory cells and restricted myelin
damage were observed in spinal cords from mice receiving
untreated DCs, and these were less apparent in spinal cords
from mice receiving LPS-DCs (Figure 7D). These data
indicate that the presence of additional DCs and more
effective virus-resistant DCs (LPS-DCs) enable susceptible SJL
mice to generate a strong virus-speciﬁc CD8
þ T cell response
and control viral persistence, resulting in resistance to
demyelinating disease. Therefore, the availability of a high
level of functionally intact DCs appears to be a critical factor
in determining resistance of the host to virus-induced
demyelinating disease, and perhaps similarly to other
infection-associated chronic diseases.
Discussion
The ability to generate a strong innate and adaptive
immune response is critical for the resistance of a host to
infectious agents [25–27]. However, many viruses can elude
immune responses by an array of diverse pathways, including
alterations in antigen presentation, cell apoptosis, and
cytokine-mediated signaling [28]. Initial TMEV infection is
successfully cleared in resistant mice, but not in susceptible
mice, leading to a chronic, MS-like demyelinating disease.
Susceptibility to persistent infection and its consequent
demyelination is likely dependent upon the balance between
viral persistence and host defense immunity. Since DCs are
potent APCs, which are essential for strong anti-viral
immunity, it would be advantageous for viruses to evade
immunological recognition and establish latency by subvert-
ing this particular cell population. However, very few
systematic comparative studies have been reported regarding
the differential susceptibility of DCs to an identical pathogen
between resistant and susceptible individuals. Here, for the
ﬁrst time to our knowledge, we provide evidence that the
differential susceptibility of DCs to viral infection between
resistant and susceptible mice leads to varying levels of DC
function in anti-viral immunity and subsequent resistance/
susceptibility to chronic demyelinating disease in these mice
(Figure 8).
It has recently been shown that generation of the anti-
TMEV CD8
þ T cell response in the CNS requires a BM-
derived APC population [29]. Similarly, induction of the T
cell response is impaired by DCs infected with foot-and-
mouth disease virus, a member of the Picornaviridae [30]. In
addition, the altered expression of accessory molecules on
DCs upon interaction with human rhinovirus leads to down-
modulation of adaptive immune responses during viral
infection [31]. In this study, we demonstrate that DCs from
SJL mice, but not B6 mice, are extremely permissive to TMEV
infection/replication (Figures 1, S1, and S2). The differential
susceptibility of DCs to TMEV infection between B6 and SJL
mice may not be restricted to this cell type; similar differ-
ential susceptibilities to viral infection were also observed in
macrophages (unpublished data). Since these cell types are
the major TMEV reservoir in the CNS [32], the differential
susceptibility of these cells may also contribute to viral
persistence in these mice. Nevertheless, resistance of DCs
from viral infection appears to be particularly important in
facilitating strong anti-viral immunity, leading to viral
clearance and protection from developing demyelinating
disease.
Furthermore, as diagrammed in Figure 8, our results
highlight a series of DC alterations that together may lead
to the reduced immune response and viral persistence in
susceptible SJL mice, whereas such alterations are not
apparent in resistant B6 mice. First, TMEV preferentially
infects immature DCs (Figure 1), blocking their differ-
entiation and activation (Figure 4). A subset of the infected
DCs undergoes apoptosis, but many arrest and fail to expand
and mature. These infected DCs may also contribute to
disease pathogenesis by altering the proﬁle of cytokines
produced and consequently by stimulating T cell subsets that
deviate from those stimulated by intact DCs (Figures 2 and 6).
In addition, the infected DCs from SJL mice produce
cytokines that lead to bystander effects, inhibiting DC
expansion and maturation in response to other stimuli such
as LPS (Figures 3 and 5).
TMEV-infected SJL DCs produce signiﬁcantly higher levels
of a variety of type I IFNs and type II IFN-c compared to B6
DCs (Figure 2). The presence of type I or II IFNs provides
protection against TMEV replication, but only when cells are
exposed to IFNs prior to viral infection, indicating a transient
nature of protection by IFNs (Figure 3). The resistance of
TMEV to type I IFNs once infection is established is similar to
previous observations in simian virus 40, respiratory syncytial
virus, dengue virus type 2, and bovine viral diarrhea virus
[33–37]. Thus, IFNs may not only limit the extent of TMEV
infection but also provide the opportunity for these viruses to
establish persistent infection. In addition, these cytokines also
inhibit the production of IL-12p40, IL-6, and TNF-a by DCs
in response to LPS stimulation (Figure 2). These results are
consistent with the previous report that type I IFNs can
negatively regulate IL-12 expression [38]. It is interesting to
note that IFN-c can also negatively regulate the production of
these inﬂammatory cytokines as well as DC expansion from
BM precursors (Figures 2 and 4). The potent inhibition of DC
expansion and function by IFN-c was unexpected, as this
cytokine is essential for strong anti-viral immunity [7,8]. As
(C) Disease courses of SJL mice infected with virus plus non-DC splenocytes (n ¼ 13), DCs (n ¼ 15), or LPS-DCs (n ¼ 15) were monitored. Data are
presented as the percentage of mice affected with a score of 1 or greater and the mean severity score and standard deviation of their clinical
manifestations.
(D) Spinal cords of infected mice at 50 dpi were stained with luxol fast blue (LFB) and hematoxylin-eosin (HE), and then examined under a light
microscope. The middle and right panels show enlarged images of the left micrographs. Scale bar ¼ 100 lm.
doi:10.1371/journal.ppat.0030124.g007
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DC function and differentiation has not been previously
described.
Notably, the signal pathways involved in the negative
regulation by type I and II IFNs may be different since IFN-c,
but not IFN-a/b, displays enhanced IL-10 induction in DCs
(Figure 2C). It has been previously reported that IFN-c can
play a negative regulatory role on DC migration and Ag-
speciﬁc T cell priming in vivo [39]. Since IFN-c is the major
cytokine produced by NK/NKT cells during early innate
responses and by CD4
þ and CD8
þ T cells during adaptive
immune responses following viral infection, IFN-c may play
an important regulatory role by switching DCs on and off for
further T cell activation. However, many studies have also
indicated that type I and II IFNs play an important role in
enhancing DC function in adaptive T cell responses [38].
Therefore, it appears paradoxical that type I and II IFNs can
confer DCs with viral resistance (Figure 3), yet these cytokines
can also inhibit DC differentiation and function (Figures 2
and 4), which are critical for strong adaptive T cell responses.
Our results here strongly suggest that the level of stimulation,
duration of stimulation, and timing of exposure to these
cytokines following viral infection affect the fate of DC
expansion and function.
TMEV infection preferentially abrogates not only matura-
tion and cytokine production by DCs infected with the virus
(producing viral proteins), but also bystander DCs (not
producing viral proteins) from susceptible SJL mice in
culture (Figures 1 and 3). This bystander inhibition is most
likely mediated by type I and II IFNs (Figures 2 and 4). Similar
deﬁciencies in DC function are likewise observed in both
CNS-associated and splenic DCs from virus-infected suscep-
tible SJL mice (Figure 5). In addition, the T cell stimulatory
function of either virus-infected BM DCs or splenic DCs from
virus-infected mice is severely compromised, particularly in
susceptible SJL mice (Figure 6). Two recent studies using
lymphocytic choriomeningitis virus and measles virus have
demonstrated that these viral infections prohibit the ex-
pansion of DCs in the spleens of mice treated with Fms-like
tyrosine kinase 3 ligand [23,40]. Therefore, it appears that
inhibition of DC expansion or function may be a common
tactic used by various viruses to evade anti-viral T cell
responses for the establishment of chronic viral persistence.
It is also noteworthy that signiﬁcantly higher levels of IL-10
are induced by LPS stimulation in virus-infected SJL DCs
than in B6 DCs (Figure 3). IL-10 production is not inhibited
after TMEV infection, unlike that of other cytokines, such as
IL-12 or TNF-a (Figure 3). High levels of IL-10 may favor Th2
development by TMEV-infected SJL DCs, in contrast to the
Th1 development promoted by uninfected DCs or virus-
infected B6 DCs (Figure 6). Interestingly, levels of IFN-c-
producing TMEV-speciﬁc CD4
þT cells are signiﬁcantly lower,
and levels of IL-10-producing CD4
þ T cells are signiﬁcantly
higher in SJL mice compared to those in B6 mice [12]. Thus,
higher IL-10 levels in susceptible SJL mice may promote viral
persistence and preferentially elicit regulatory T cells, which
further suppress anti-viral responses. Consistent with this
notion, HIV-1-infected monocyte-derived DCs do not under-
go maturation, but can elicit IL-10 production and T cell
regulation [41]. Furthermore, IL-10 may also directly induce
immunosuppression, facilitating viral persistence in vivo as
recently shown in the lymphocytic choriomeningitis virus
model [42,43]. Alternatively, it is possible that TMEV-induced
t y p eII F N si nD C se x e r tar e g u l a t o r yr o l ei nT h 1 / 2
development; one study showed that exposure to IFN-b
during DC-mediated stimulation of naı ¨ve Th cells inhibits
Th1 cell polarization and promotes the generation of an IL-
10-secreting T cell subset [44]. Therefore, it appears that the
alteration of IL-10 production is an immune evasion
mechanism frequently used by many different pathogenic
viruses. Susceptibility to this alteration may also be a critical
factor for chronic viral persistence leading to various
inﬂammatory diseases.
I ns u m m a r y ,w eh a v ed e m o n s t r a t e dt h a tD C sf r o m
susceptible SJL mice are considerably more permissive to
initial viral infection and replication compared to DCs from
resistant B6 mice. In addition, TMEV infection preferentially
inhibits maturation, activation, and T cell–stimulating func-
Figure 8. Schematic Presentation of the Potential Role of DCs in
Differential Susceptibility to Viral Persistence
TMEV preferentially infects immature DCs and induces the production of
anti-viral IFN-a/b, IFN-c, and unknown cytokines. DCs from susceptible
mice are more permissive to viral infection and viral-induced apoptosis,
and produce higher levels of these cytokines compared to DCs from
resistant mice. These cytokines inhibit the development of DCs from BM
cells in a dose-dependent manner, leading to arrested maturation and
compromised function, while these cytokines can be protective when
exposed to DCs prior to viral infection. Consequently, susceptible mice
exhibit severely reduced levels of functionally mature DCs for T cell
activation, resulting in poor anti-viral T cell responses, and perhaps,
preferential non-protective or pathogenic T cell responses. Adoptive
transfer of LPS-pre-activated syngeneic DCs, which are resistant to viral
infection, renders susceptible mice resistant to viral-induced demyelinat-
ing disease by elevating protective T cell responses.
doi:10.1371/journal.ppat.0030124.g008
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The impaired function and reduced number of DCs are likely
to add to the poor anti-viral T responses observed in virus-
infected susceptible mice, contributing to establishment of
persistent infection. It is quite striking to note that such
deﬁciencies and/or abnormalities of DC function are not
apparent after TMEV infection in resistant B6 mice.
Furthermore, the adoptive transfer of DCs, particularly pre-
activated DCs resistant to viral infection, results in the
effective clearance of viral persistence and protection from
the development of demyelinating disease in susceptible SJL
mice (Figure 7). Therefore, the differential responses of DCs
to infectious agents may determine the outcome of diseases
associated with chronic infections. Our results strongly
suggest that increasing DC populations in the target organs
and arming them against infections may provide a useful
intervention for acute or chronic infection-associated dis-
eases.
Materials and Methods
Mice. Female SJL, B6, and BALB/c mice were purchased from
Harlan Sprague Dawley (http://www.harlan.com/). IFN-a/b receptor
knockout mice (IFN-a/bR) were kindly provided by Herbert (Skip)
Virgin (Washington University, St. Louis, Missouri, United States),
and control 129S2/SvPas mice (IFN-a/bR) were purchased from
Charles River Laboratories (http://www.crviver.com/). Mice (6–8 weeks
old) were maintained and used according to protocols approved by
the Northwestern University Animal Care and Use Committee.
Reagents. The reagents used include IFN-a, IFN-b (both Invitro-
gen, http://www.invitrogen.com/), and IFN-c, IL-6 (both PeproTech,
http://www.peprotech.com/).
Virus preparation and infection of mice. The BeAn strain of TMEV
was propagated and titered in baby hamster kidney (BHK) cells grown
in DMEM supplemented with 7.5% donor calf serum, as previously
described [11]. TMEV or virus-infected DC supernatant was inacti-
vated by exposure to a UV light source for 60 min at 4 8C [45]. The
complete inactivation of virus after irradiation was conﬁrmed by the
absence of viral plaque formation on BHK-21 cells. Mice were
infected by intracerebral inoculation of 30 ll( 13 10
6 pfu) of the
BeAn strain of TMEV, and clinical symptoms of disease were assessed
weekly on the following grading scale as previously described [46]:
grade 0 ¼ no clinical signs; grade 1 ¼ mild waddling gait; grade 2 ¼
moderate waddling gait and hind limb paresis; grade 3 ¼ severe hind
limb paralysis; grade 4¼severe hindlimb paralysis and loss of righting
reﬂex.
Generation of BM DCs and expansion. BM cells were harvested
from femurs and tibias of SJL or B6 mice and cultured in RPMI-10
with 20 ng/ml murine rGM-CSF (PeproTech) as described [47]. On day
5, predominantly immature DCs were obtained. For DC expansion
experiments, BMCs cultured for 3 d were collected and used as
indicated.
Isolation of CNS inﬁltrated leukocytes. Mice were perfused with 30
ml HBSS. Brains and spinal cords were forced through steel mesh and
digested at 37 8C for 45 min in HBSS containing 250 lg/ml
collagenase type 4 (Worthington Biochemical, http://www.
worthington-biochem.com/). CNS inﬁltrated leukocytes were then
enriched on a continuous Percoll (Amersham Biosciences, http://www.
gelifesciences.com/) gradient as described [11].
Virus binding and infection assays. For the binding assay, BM DCs
on day 5 of the culture were incubated with TMEV (MOI 10) for 1 h at
4 8C, ﬁxed with 1% PFA, and stained with monoclonal antibody
(mAb) (8C) to the TMEV VP2 capsid protein followed by FITC-
conjugated goat anti-mouse Ig (Invitrogen) [6]. For TMEV infection,
BMCs were incubated with TMEV (MOI 10) for 1 h at 20 8C with
intermittent shaking in RPMI with 0.1% bovine serum albumin
(infection medium). Cells were washed twice and then resuspended in
complete RPMI-10 medium containing 10% FCS, 20 ng/ml GM-CSF,
and 5 3 10
5 cells per well in a 24-well plate. For the infection assay,
monensin (0.7 ll/ml, GolgiStop; BD PharMingen, http://www.
bdbiosciences.com/) was added for the ﬁnal 4 h of infection cultures.
Cells were ﬁxed, permeabilized (perm/ﬁx solution, BD PharMingen),
blocked with 1% normal goat serum (Invitrogen), and stained with 8C
mAb followed by FITC-conjugated secondary antibody or PE-
conjugated goat anti-mouse Ig (BD PharMingen). Cells were
subsequently stained with anti-CD11c-APC (BD PharMingen). La-
beled cells were analyzed on a FACSCalibur ﬂow cytometer. For the
maturation-associated marker assay, DCs on day 5 of the culture were
infected for 24 h. Cells were stained as described in the infection
assay and were further labeled with anti-rat RT1B-FITC (which cross-
reacts with mouse I-A
k and I-A
s alloantigens), anti-I-A
b-FITC, anti-
CD86-FITC (all BD PharMingen), and anti-CCR7-PE (eBioscience,
http://www.ebioscience.com/).
Activation of DCs with LPS and assessment of cytokine production.
In order to determine the effect of LPS on TMEV replication in DCs,
100 ng/ml LPS (Escherichia coli 0111:B4) (Sigma-Aldrich, http://www.
sigmaaldrich.com/) were added to DCs on day 5 of the cultures for the
indicated time periods. To determine the anti-viral effect of LPS or
cytokines, DCs were pretreated for 6 h with these reagents, washed
twice, and then infected with TMEV for 24 h. IL-12p40, IL-6, TNF-a,
and IL-10 in supernatants of DC cultures at 24 h after infection were
measured using BD OptEIA ELISA Set, and IFN-a was determined
using an ELISA kit (PBL Biomedical Laboratories, http://www.
interferonsource.com/).
Plaque assay. Culture supernatants of DCs infected with TMEV for
varying time periods were collected for a standard plaque assay on
BHK-21 monolayers [11]. In order to analyze viral persistence in vivo,
brains and spinal cords were removed from virus-infected mice at 7
or 21 dpi after cardiac perfusion with HBSS. Tissue homogenate was
used to perform a standard plaque assay.
Detection of intracellular cytokines and cytokines in supernatants.
SJL DCs were pretreated with IFN-a, IFN-b, IFN-c, or IL-6 for 18 h
and then stimulated with PBS or 100 ng/ml LPS for 6 h. Supernatants
were collected to determine cytokine production and cells were
stained for intracellular cytokine production. CNS-inﬁltrated leuko-
cytes at 5 dpi and splenocytes at 7 dpi were cultured for 6 h with 20
ng/ml GM-CSF in the absence or presence of LPS. Monensin was
added for the ﬁnal 4 h of culture. DCs were ﬁxed, permeabilized, and
then stained with anti-CD11c-APC and anti-IL-12p40/p70-PE or anti-
TNF-a-PE (both BD PharMingen). To analyze cytokine production by
splenic DCs, DCs were positively selected by using anti-CD11c
MicroBead (Miltenyi Biotec, http://www.miltenyibiotec.com/) from
the spleens of virus-infected mice at 7 dpi. Cultures were further
incubated for 24 h in medium containing 20 ng/ml GM-CSF, with or
without LPS (100 ng/ml) during the last 6 h of culture. Supernatants
were collected to determine IL-12p40 levels. For the cytokine
production assay from T cell cultures, supernatants were collected
96 h later. IFN-c and IL-4 were measured using BD OptEIA ELISA
Set.
Real-time PCR. Total RNA was isolated from SJL DCs or B6 DCs
infected with or without TMEV for 8 h, using Trizol (GIBCO BRL,
http://www.invitrogen.com/) by the manufacturer’s instructions. Re-
verse transcription was performed using 1–3 lg of total RNA. The
sense and antisense primer sequences used are as follows: IFN-a1 (5-
TAGGCTCTGTGCTTTCCTGATGGT-3 and 5-GGTTGCATTC-
CAAGCAGCAGAT GA-3), IFN-a7 (5-AAGGACT-
CATCTGCTGCTTGGGAT-3 and 5-ACTCAATCTTGCCAGCAACT
TGGC-3), IFN-a11 (5-TCAAACACACAGTCCAGAGAGCCA-3 and
5-ATCCAAAGTCCTGC CTGTCCTTCA-3), IFN-b (5-
GCTCGAGCCCCAGGGAATGAACAACAGG TGG-3 and 5-
GCTCGAGTCCCTGGGGGTTTTGGAAGTTTCT-3), IFN-c (5-
ACTGGCAA AAGGAT GGTGAC-3 and 5-TGAGCTCATT-
GAATGCTTGG-3), and GADPH (5-AACTTTGGC ATTGTG-
GAAGG-3 and 5-ACACATTGGGGGTAGGAACA-3). Speciﬁc RNA
messages were ampliﬁed in iCycler SYBR green I mastermix (Bio-Rad,
http://www.bio-rad.com/), using an iCycler (Bio-Rad). Quantiﬁcation
of the genes of interest was normalized to GAPDH in each cDNA and
was expressed by fold increase compared with mock-infected DCs. All
real-time PCR was performed in triplicate.
Apoptosis assays. For the BM DC apoptosis assay, DCs obtained
from a 3-d BM culture were infected with TMEV for 24 h and then
either stained with FITC-conjugated Annexin V (Invitrogen) or
labeled with Annexin V MicroBead (Miltenyi Biotec) for cell
separation. The Annexin V–positive and –negative cells were
separated, ﬁxed, permeabilized, and stained with anti-TMEV mAb
and anti-CD11c antibody.
Proliferation and MLR assays. BMCs on day 3 of the culture were
labeled with CFSE (Molecular Probes, http://probes.invitrogen.com/)
and then infected with TMEV. After 3 d of incubation, cells were
stained with anti-CD11c-APC and the level of proliferation was
assessed using FACS. Primary allogeneic MLR was performed with
mock-infected or virus-infected BM DCs at 3 dpi that were unﬁxed or
ﬁxed with 0.1% PFA as described [48]. DCs from the spleens of mock-
infected or TMEV-infected mice were positively selected by using
PLoS Pathogens | www.plospathogens.org August 2007 | Volume 3 | Issue 8 | e124 1048
Dendritic Cells in Chronic Viral Infectionanti-CD11c MicroBead (Miltenyi Biotec) at 7 dpi. Responder T cells
from naı ¨ve BALB/c mice were enriched from spleens by depleting
adherent cells at 37 8C for 2 h and then negatively selected by using
anti-CD19 MicroBead (Miltenyi Biotec) to remove B cells. Varying
numbers of DCs were cocultured with puriﬁed T cells (10
5/well) in 200
ll of RPMI-10. The cultures were then incubated for 96 h, followed by
an 18-h pulse with 1 lCi of [
3H]-thymidine/well (Amersham
Biosciences). For the T cell activation assay, cells were collected 96
h later and stained with anti-CD4-APC, anti-CD8-FITC, and anti-
CD69-PE (all BD PharMingen) or anti-TIM-3-PE (eBioscience).
Adoptive DC transfer in combination with TMEV infection. SJL
DCs cultured for 5 d were stimulated with or without 100 ng/ml LPS
for 6 h (LPS-DCs) and then washed twice. The cell pellets were then
resuspended in DMEM and incubated with TMEV (MOI 10) for 30
min at 4 8C. Non-DC splenocytes depleted of DCs by anti-CD11c
MicroBead (Miltenyi Biotec) were used as an irrelevant cell type
control. Mice were infected by intracerebral inoculation of 30 ll
containing 1 3 10
5 cells and/or 1 3 10
6 pfu TMEV. In addition, mice
were injected with LPS-DCs alone as an additional control group.
Histology. Spinal cords were removed at 50 dpi after perfusion as
described above, ﬁxed in 10% buffered PFA overnight, and then
embedded in parafﬁn. Sections were stained with luxol fast blue
(myelin stain) and hematoxylin-eosin, and then analyzed by micro-
scopy. Ten different sections of the lumbar region of the spinal cord
of individual mice were evaluated for demyelination. A representa-
tive set of micrographs is shown.
Statistical analysis. Results are expressed as mean 6 SD, where
applicable. The Student’s t test was used to compare two independent
groups. The differences in mean severity scores of the two
experimental groups were compared between 21 and 98 dpi by using
a paired Student’s t test. Multiple group comparisons were done by a
one-way analysis of variance (ANOVA) with Tukey post-hoc analysis.
p-Values , 0.05 were considered to be signiﬁcant.
Supporting Information
Figure S1. CD11c
þ Cells Are the Major Virus-Infected Population in
the BM Cell Culture
(A) Experimental scheme of cell separation and determination of
viral infection levels of subpopulations in BM cultures. Five-day
cultured BM cells were infected with TMEV (MOI 10) for 1 h at 20 8C.
After washing, cells were separated using anti-CD11c-coated mag-
netic beads (Miltenyi Biotec). Separated CD11c
þand CD11c
 cells and
unseparated BMCs from aliquots of the same BMC preparation were
then cultured for 24 h with 20 ng/ml GM-CSF.
(B) Expression of TMEV proteins in cells was determined using ﬂow
cytometry after staining with anti-TMEV mAb and anti-CD11c
antibody.
(C) Virus titers in the culture supernatants of the separated cells were
analyzed by plaque assay. The differences between the values of
separated and unseparated cells are extremely signiﬁcant (***, p ,
0.001), as indicated by asterisks.
(D) Puriﬁed splenic DCs by positive selection using anti-CD11c-
coated MicroBeads were infected with TMEV (MOI 10) for 24 h. The
culture supernatants were collected 24 h post-infection and the level
of replicating TMEV was determined by plaque assay. Statistical
differences compared to the values of SJL DCs are indicated by
asterisks (*, p , 0.05). UD, undetectable.
Found at doi:10.1371/journal.ppat.0030124.sg001 (7.1 MB PDF).
Figure S2. MHC Haplotype H-2
b Is Not Required for DC Resistance
to Viral Infection
BM DCs from B10.S and their counterpart control mice (B10 and SJL)
were infected with TMEV (MOI 10) for 24 h. Expression of TMEV
proteins was assessed using anti-TMEV mAb and anti-CD11c anti-
body. DCs from B10.S mice exhibiting susceptible H-2
s display
resistance to TMEV infection similar to that of B10 mice carrying
resistant H-2
b haplotype.
Found at doi:10.1371/journal.ppat.0030124.sg002 (10.5 MB PDF).
Figure S3. Lower DC Numbers Are Present in Virus-Infected
Susceptible SJL Mice
(A) The level of CD11c
þ cells per femur/tibia or spleen is shown. Each
symbol represents the cell frequency or number in each mouse. The
average of each group is denoted with horizontal bar.
(B) BM cells and splenocytes from mock-infected (ﬁlled histogram) or
TMEV-infected (open histogram) mice were stained with CD11c, PI,
and Annexin V at 2, 4, and 7 dpi. Live DCs (CD11c
þ PI
  cells) were
assessed with Annexin V. Relative mean ﬂuorescence intensity of DCs
from TMEV-infected mice, differing from the values of DCs from
mock-infected mice, is depicted on graphs.
Found at doi:10.1371/journal.ppat.0030124.sg003 (4.6 MB PDF).
Figure S4. DC Subpopulation Distribution Is Different between
TMEV-Infected SJL and B6 Mice
(A) The expression of CD45, CD11c and CD11b, CD8a, or CD45RA on
CNS-inﬁltrating cells was assessed at 5 dpi. Data represent the cells
gated with CD45
hi cells. The percentage of CD11b-, CD8a-, or
CD45RA-positive cells within the CD45
hiCD11c
þ population was
shown in the FACS plots.
(B) The expression of CD8a and CD45RA molecules on gated CD11c
þ
splenocytes was determined at 7 dpi by FACS.
Found at doi:10.1371/journal.ppat.0030124.sg004 (3.4 MB PDF).
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